Publication Results

Generate Report

Add publications by marking their checkboxes, or

Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention.

Ingle JN,  Liu M,  Wickerham DL,  Schaid DJ,  Wang L,  Mushiroda T,  Kubo M,  Costantino JP,  Vogel VG,  Paik S,  Goetz MP,  Ames MM,  Jenkins GD,  Batzler A,  Carlson EE,  Flockhart DA,  Wolmark N,  Nakamura Y,  Weinshilboum RM
Cancer Discov 2013 Jul;3(7):812-25
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 23764426
PMC ID: PMC3710533
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR) ;  Breast Cancer Prevention Trial (BCPT)

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.

Cuzick J,  Sestak I,  Bonanni B,  Costantino JP,  Cummings S,  DeCensi A,  Dowsett M,  Forbes JF,  Ford L,  LaCroix AZ,  Mershon J,  Mitlak BH,  Powles T,  Veronesi U,  Vogel V,  Wickerham DL,  SERM Chemoprevention of Breast Cancer Overview Group
Lancet 2013 May 25;381(9880):1827-34
Major Program(s) or Research Group(s): Lung and Upper Aerodigestive CancerCommunity Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 23639488
PMC ID: PMC3671272
Clinical Trials: Breast Cancer Prevention Trial (BCPT) ;  Study of Tamoxifen and Raloxifene (STAR)

National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial: advancing the science of recruitment and breast cancer risk assessment in minority communities.

McCaskill-Stevens W,  Wilson JW,  Cook ED,  Edwards CL,  Gibson RV,  McElwain DL,  Figueroa-Moseley CD,  Paskett ED,  Roberson NL,  Wickerham DL,  Wolmark N
Clin Trials 2013 Apr;10(2):280-91
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 23335675
PMC ID: PMC4059676
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Positive and negative affect, depression, and cognitive processes in the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Trial.

Danhauer SC,  Legault C,  Bandos H,  Kidwell K,  Costantino J,  Vaughan L,  Avis NE,  Rapp S,  Coker LH,  Naughton M,  Naylor C,  Terracciano A,  Shumaker S
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2013;20(5):532-52
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 23237718
PMC ID: PMC3815441
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR).

Cecchini RS,  Costantino JP,  Cauley JA,  Cronin WM,  Wickerham DL,  Bandos H,  Weissfeld JL,  Wolmark N
Cancer Prev Res (Phila) 2012 Nov;5(11):1321-9
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 23060039
PMC ID: PMC4131535
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene.

Powles TJ,  Diem SJ,  Fabian CJ,  Neven P,  Wickerham DL,  Cox DA,  Muram D,  Agnusdei D,  Dowsett SA,  Amewou-Atisso M,  Cummings SR
Breast Cancer Res Treat 2012 Jul;134(1):299-306
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 22484799
PMC ID: not available
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Using the gene ontology to scan multilevel gene sets for associations in genome wide association studies.

Schaid DJ,  Sinnwell JP,  Jenkins GD,  McDonnell SK,  Ingle JN,  Kubo M,  Goss PE,  Costantino JP,  Wickerham DL,  Weinshilboum RM
Genet Epidemiol 2012 Jan;36(1):3-16
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 22161999
PMC ID: PMC3310255
Clinical Trials: Breast Cancer Prevention Trial (BCPT) ;  Study of Tamoxifen and Raloxifene (STAR)

Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR).

Runowicz CD,  Costantino JP,  Wickerham DL,  Cecchini RS,  Cronin WM,  Ford LG,  Vogel VG,  Wolmark N
Am J Obstet Gynecol 2011 Dec;205(6):535.e1-5
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program ;  Office of the Director
PubMed ID: 21872200
PMC ID: PMC5160016
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials.

Goetz MP,  Schaid DJ,  Wickerham DL,  Safgren S,  Mushiroda T,  Kubo M,  Batzler A,  Costantino JP,  Vogel VG,  Paik S,  Carlson EE,  Flockhart DA,  Wolmark N,  Nakamura Y,  Weinshilboum RM,  Ingle JN,  Ames MM
Clin Cancer Res 2011 Nov 1;17(21):6944-51
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 21880792
PMC ID: PMC3207003
Clinical Trials: Breast Cancer Prevention Trial (BCPT) ;  Study of Tamoxifen and Raloxifene (STAR)

Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older.

Freedman AN,  Yu B,  Gail MH,  Costantino JP,  Graubard BI,  Vogel VG,  Anderson GL,  McCaskill-Stevens W
J Clin Oncol 2011 Jun 10;29(17):2327-33
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 21537036
PMC ID: PMC3107748
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Estimated risk of invasive breast cancer in postmenopausal women with and without family history of the disease.

Sontag A,  Wickerham L,  Ni X,  Mitchell BD,  Helt C,  Muram D
Menopause 2011 May;18(5):515-20
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 21178791
PMC ID: not available
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Identification of accrual barriers onto breast cancer prevention clinical trials: a case-control study.

Houlihan RH,  Kennedy MH,  Kulesher RR,  Lemon SC,  Wickerham DL,  Hsieh CC,  Altieri DC
Cancer 2010 Aug 1;116(15):3569-76
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 20564133
PMC ID: PMC3077438
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Breast cancer chemoprevention: progress and controversy.

Wickerham DL
Surg Oncol Clin N Am 2010 Jul;19(3):463-73
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 20620921
PMC ID: PMC3034655
Clinical Trials: Breast Cancer Prevention Trial (BCPT) ;  Study of Tamoxifen and Raloxifene (STAR)

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.

Vogel VG,  Costantino JP,  Wickerham DL,  Cronin WM,  Cecchini RS,  Atkins JN,  Bevers TB,  Fehrenbacher L,  Pajon ER,  Wade JL 3rd,  Robidoux A,  Margolese RG,  James J,  Runowicz CD,  Ganz PA,  Reis SE,  McCaskill-Stevens W,  Ford LG,  Jordan VC,  Wolmark N,  National Surgical Adjuvant Breast and Bowel Project
Cancer Prev Res (Phila) 2010 Jun;3(6):696-706
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program ;  Community Clinical Oncology Program
PubMed ID: 20404000
PMC ID: PMC2935331
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition.

Espeland MA,  Shumaker SA,  Limacher M,  Rapp SR,  Bevers TB,  Barad DH,  Coker LH,  Gaussoin SA,  Stefanick ML,  Lane DS,  Maki PM,  Resnick SM
J Womens Health (Larchmt) 2010 Mar;19(3):371-9
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program ;  Community Clinical Oncology Program
PubMed ID: 20136553
PMC ID: PMC2867626
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Carcinoma in situ outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention Trials.

Vogel VG,  Costantino JP,  Wickerham DL,  McCaskill-Stevens W,  Clarfeld RB,  Grant MD,  Wolmark N
J Natl Cancer Inst Monogr 2010;2010(41):181-6
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 20956826
PMC ID: PMC5161067
Clinical Trials: Breast Cancer Prevention Trial (BCPT) ;  Study of Tamoxifen and Raloxifene (STAR)

Effects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene.

Legault C,  Maki PM,  Resnick SM,  Coker L,  Hogan P,  Bevers TB,  Shumaker SA
J Clin Oncol 2009 Nov 1;27(31):5144-52
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program ;  Community Clinical Oncology Program
PubMed ID: 19770382
PMC ID: PMC2773473
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

The NSABP Study of Tamoxifen and Raloxifene (STAR) trial.

Vogel VG
Expert Rev Anticancer Ther 2009 Jan;9(1):51-60
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 19105706
PMC ID: PMC2785111
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Projecting individualized absolute invasive breast cancer risk in African American women.

Gail MH,  Costantino JP,  Pee D,  Bondy M,  Newman L,  Selvan M,  Anderson GL,  Malone KE,  Marchbanks PA,  McCaskill-Stevens W,  Norman SA,  Simon MS,  Spirtas R,  Ursin G,  Bernstein L
J Natl Cancer Inst 2007 Dec 5;99(23):1782-92
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program ;  Community Clinical Oncology Program
PubMed ID: 18042936
PMC ID: not available
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Land SR,  Wickerham DL,  Costantino JP,  Ritter MW,  Vogel VG,  Lee M,  Pajon ER,  Wade JL 3rd,  Dakhil S,  Lockhart JB Jr,  Wolmark N,  Ganz PA
JAMA 2006 Jun 21;295(23):2742-51
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 16754728
PMC ID: not available
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Vogel VG,  Costantino JP,  Wickerham DL,  Cronin WM,  Cecchini RS,  Atkins JN,  Bevers TB,  Fehrenbacher L,  Pajon ER Jr,  Wade JL 3rd,  Robidoux A,  Margolese RG,  James J,  Lippman SM,  Runowicz CD,  Ganz PA,  Reis SE,  McCaskill-Stevens W,  Ford LG,  Jordan VC,  Wolmark N,  National Surgical Adjuvant Breast and Bowel Project (NSABP)
JAMA 2006 Jun 21;295(23):2727-41
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program ;  Office of the Director ;  Community Clinical Oncology Program
PubMed ID: 16754727
PMC ID: not available
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.

Vogel VG,  Costantino JP,  Wickerham DL,  Cronin WM
Clin Cancer Res 2003 Jan;9(1 Pt 2):495S-501S
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 12538506
PMC ID: not available
Clinical Trials: Breast Cancer Prevention Trial (BCPT) ;  Study of Tamoxifen and Raloxifene (STAR)